Pharma experts identify the true cost of product loss

These events act as a reminder of how far we have come as an Association but they also remind us of why TAPA is so important and the increasing level of risk facing global supply chains. As we know, there is no finishing line in the fight against organised criminals that are targeting high value, theft attractive products. The best we can do is to stay one step ahead. In the last issue of Vigilant, we announced the outcome of our Board election and since then the Board has met and agreed our respective roles for the new three-year term of office. I am extremely proud to be continuing as Chairman of TAPA EMEA and to be working alongside so many supply chain security experts on the Board. The growth of TAPA, the continuous improvements to our Security Standards, the intelligence we provide, and the training we deliver are all driven by the volunteers on our Board and I know this will continue. Despite all having highly responsible and demanding day jobs, every member of the TAPA EMEA.

Spotlight

United Health Solutions Brazil

Provide solutions in health management, with qualified and motivated teams, reaching a new level in terms of excellence in medical and dental care. Expand the network accredited nationally and internationally, thus making it possible to serve the largest number of quality clients in various parts of the world.

OTHER WHITEPAPERS
news image

Medical Afairs Transformation in Specialty Pharma

whitePaper | March 6, 2022

Pharmaceutical companies with a medical mindset and an empowered Medical Afairs function are well equipped to meet the needs and expectations of patients and society. Yet, as capacity to understand and serve those needs accelerates.

Read More
news image

Patients Diagnosed with Post-COVID Conditions

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern.

Read More
news image

Understanding the true cost of transparency reporting

whitePaper | December 14, 2022

When the regulatory hammer came down on pharmaceutical and life sciences (PLS) companies in the 2010s, it introduced new complexities for these businesses.

Read More
news image

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis

whitePaper | June 28, 2022

CF is a rare, autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene that encodes the CFTR protein, an anion channel normally present in the epithelial membrane.1,2

Read More
news image

Overcoming The Challenges of Pediatric Formulation

whitePaper | February 15, 2023

Pediatric populations represent the most diverse patient groups in all of medicine. Factors such as individual preferences, physiology, and dosage considerations all serve to complicate drug formulation aimed at pediatric care.

Read More
news image

THE PHARMACEUTICAL INDUSTRY AND GLOBAL HEALTH

whitePaper | January 31, 2022

COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was first identified in December 2019.

Read More

Spotlight

United Health Solutions Brazil

Provide solutions in health management, with qualified and motivated teams, reaching a new level in terms of excellence in medical and dental care. Expand the network accredited nationally and internationally, thus making it possible to serve the largest number of quality clients in various parts of the world.

Events